Keenova Therapeutics plc announced today that it reached a milestone: 100,000 patients with Peyronie's disease (PD) have been prescribed XIAFLEX® (collagenase clostridium histolyticum).1* ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback